Allarae is an international developer and distributor of advanced biotechnology and personal health screening products. Allarae’s monitoring kits include screenings for influenza, breast cancer, strep throat and prostate cancer, and in the near future the company anticipates distributing HIV, hepatitis, malaria and heart disease screening products. These devices, which help in the early screening and detection of major illnesses, are becoming more available to consumers and more accepted by the professional medical community.
The healthcare system in the United States has become increasingly complex, leading many consumers and professionals to take matters into their own hands as the two groups start to realize that it is their personal responsibility to monitor and improve individual and family health. It is Allarae’s goal to provide consumers with the technology and products necessary to change the health landscape in their favor. Allarae’s diagnostics provide the means to early detection and diagnosis of catastrophic illnesses.
The healthcare industry is one of the most rapidly growing sectors in the American economy. We currently have healthcare expenditures per capital that are anywhere from two to three times that of other developed countries, and in the next 10 years those costs are anticipated to increase by as much as 83%. Coming into the election, Americans rank healthcare amount the top 5 concerns for the nation.
Our hospitals and doctors annually rank among the top when it comes it comes to emergency care, sicknesses and broken bones, but when it comes to the diagnosis and early detection of life threatening diseases, we leave a lot to be desired. Allarae is hoping that they will be able to boost those ratings through the development and distribution of their products to both consumers and medical professionals. They hope to put the power of early detection into the hands of those who need it.
Let us hear your thoughts: Allarae Healthcare, Inc. Message Board